# Efficacy and Safety of 2 Dosing Regimens of T1225 Eye Drops 1.5% Versus Oral Azithromycin in Treatment of Trachoma

> **NCT00356720** · PHASE3 · COMPLETED · sponsor: **Laboratoires Thea**

## Conditions studied

- Trachoma

## Interventions

- **DRUG:** Azithromycin

## Key facts

- **NCT ID:** NCT00356720
- **Lead sponsor:** Laboratoires Thea
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-01
- **Primary completion:** —
- **Final completion:** 2004-05
- **Target enrollment:** — (—)
- **Last updated:** 2006-07-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00356720

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00356720, "Efficacy and Safety of 2 Dosing Regimens of T1225 Eye Drops 1.5% Versus Oral Azithromycin in Treatment of Trachoma". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00356720. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*